Pegvisomant

Pegvisomant is a medication used to treat acromegaly, a condition caused by excessive growth hormone, often due to a tumor on the pituitary gland. It works by blocking the effects of growth hormone in the body, helping to reduce symptoms like enlarged hands, feet, and facial features. Pegvisomant is a genetically engineered drug, meaning it is produced using biotechnology. It is administered as an injection and is typically used when other treatments are ineffective or unsuitable. Overall, it helps improve quality of life for people with acromegaly by controlling hormone levels and alleviating symptoms.